1-7 of 7
Jennifer Peterson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Iopofosine I 131 in Previously Treated Patients with Waldenström Macroglobulinemia (WM): Efficacy and Safety Results from the International, Multicenter, Open-Label Phase 2 Study (CLOVER-WaM™)

Sikander Ailawadhi, Maria Gavriatopoulou, Jennifer Peterson, Ioannis Ntanasis-Stathopoulos, Ghassan El-Haddad, Ariel Grajales-Cruz, Aimaz Afrough, Moshe Y. Levy, Judith Trotman, Kimberly R. Doucette, Jorge J. Castillo, Francisco Hernandez-Ilizaliturri, Ajay K. Nooka, Shirley D'Sa, Ralph V. Boccia, Harsh Parmar, Carlos Fernández de Larrea, Guldane Cengiz Seval, Luiza Beatriz Goncalves Beber, Radhakrishnan Ramchandren, Sheeba K. Thomas, Jarrod Longcor, Andrei Shustov, Larry D Anderson, Jr.
Journal: Blood
Blood (2024) 144 (Supplement 1): 861.
https://doi.org/10.1182/blood-2024-200277
Published: 2024
Journal Articles

Bridging Radiotherapy for Patients with Limited (<5 Disease Sites) Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Prior to CAR T-Cell Therapy

Omran Saifi, William Breen, Scott Lester, William Rule, Bradley Stish, Allison C. Rosenthal, Javier Munoz, Yi Lin, Patrick B Johnston, Stephen M Ansell, Jonas Paludo, Arushi Khurana, Jose. C. Villasboas, Yucai Wang, Madiha Iqbal, Muhamad Alhaj Moustafa, Hemant S. Murthy, Ernesto Ayala, Mohamed A. Kharfan-Dabaja, Jennifer Peterson, Bradford Hoppe
Journal: Blood
Blood (2023) 142 (Supplement 1): 2127.
https://doi.org/10.1182/blood-2023-186806
Published: 2023
Journal Articles

Utilization and Cost Effectiveness of First-Line Yttrium-90 Ibritumomab Tiuxetan in Low-Grade Follicular and Marginal Zone Lymphomas Compared to Standard of Care Bendamustine Plus Rituximab: A Real-World Experience

Muhamad Alhaj Moustafa, Bijan J Borah, James P Moriarty, Ruchita Dholakia, Liuyan Jiang, Bradford Hoppe, Jennifer Peterson, James R. Cerhan, Han W. Tun
Journal: Blood
Blood (2021) 138 (Supplement 1): 4020.
https://doi.org/10.1182/blood-2021-153351
Published: 2021
Journal Articles

Metabolic PET/CT Analysis of Aggressive Non-Hodgkin Lymphoma Prior to Axicabtagene Ciloleucel CAR-T Infusion: Predictors of Progressive Disease, Survival, and Toxicity

William Breen, Jason R. Young, Matthew Hathcock, Roman O. Kowalchuk, Radhika Bansal, Arushi Khurana, N. Nora Bennani, Jonas Paludo, Jose C. Villasboas, Yucai Wang, Stephen M. Ansell, Jennifer Peterson, Patrick B. Johnston, Scott Lester, Yi Lin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2518.
https://doi.org/10.1182/blood-2021-153739
Published: 2021
Journal Articles

Long-Term Outcome of Patients with Low-Grade Follicular Lymphoma Treated with Yttrium-90 Ibritumomab Tiuxetan: The Mayo Clinic Experience

Muhamad Alhaj Moustafa, MD, Ricardo Parrondo, MD, Gregory Wiseman, MD, Jennifer Peterson, MD, Thomas E. Witzig, MD, Han W. Tun, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2809.
https://doi.org/10.1182/blood-2019-129391
Published: 2019
Journal Articles

Long-Term Outcome of Patients with Marginal Zone Non-Hodgkin Lymphoma (MZL) Treated with Yttrium-90 Ibritumomab Tiuxetan: The Mayo Clinic Experience

Muhamad Alhaj Moustafa, MD, Ricardo Parrondo, MD, Gregory Wiseman, MD, Jennifer Peterson, MD, Thomas E. Witzig, MD, Han W. Tun, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1544.
https://doi.org/10.1182/blood-2019-130384
Published: 2019
Journal Articles

Therapy with Ibritumomab Tiuxetan (Zevalin ® ) in Patients with Previously Untreated and Relapsed Low Grade Follicular Lymphoma: The Mayo Clinic Florida Experience, 2000-2016

Aixa Elena Soyano, MD, Ryan D Frank, MS, Han W Tun, MD, Jennifer Peterson, MD
Journal: Blood
Blood (2016) 128 (22): 5324.
https://doi.org/10.1182/blood.V128.22.5324.5324
Published: 2016